Simone Boehrer

2.6k total citations
68 papers, 1.7k citations indexed

About

Simone Boehrer is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Simone Boehrer has authored 68 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 33 papers in Hematology and 23 papers in Genetics. Recurrent topics in Simone Boehrer's work include Acute Myeloid Leukemia Research (26 papers), Cell death mechanisms and regulation (21 papers) and Chronic Lymphocytic Leukemia Research (18 papers). Simone Boehrer is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Cell death mechanisms and regulation (21 papers) and Chronic Lymphocytic Leukemia Research (18 papers). Simone Boehrer collaborates with scholars based in Germany, France and United States. Simone Boehrer's co-authors include Dieter Hoelzer, Kai Uwe Chow, Paris S. Mitrou, Pierre Fenaux, Guido Kroemer, Lionel Adès, Martin Ruthardt, Eckhart Weidmann, Bernd Schneider and Claude Gardin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular Cell.

In The Last Decade

Simone Boehrer

68 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Boehrer Germany 24 1.0k 620 415 367 262 68 1.7k
Carmela Gurrieri Italy 18 915 0.9× 360 0.6× 304 0.7× 393 1.1× 196 0.7× 46 1.5k
Yosuke Minami Japan 22 802 0.8× 812 1.3× 355 0.9× 395 1.1× 157 0.6× 103 1.6k
Seong Lin Khaw Australia 17 958 1.0× 477 0.8× 440 1.1× 440 1.2× 252 1.0× 37 1.6k
Keita Kirito Japan 29 1.2k 1.2× 1.1k 1.7× 585 1.4× 433 1.2× 206 0.8× 128 2.3k
Francesca Arruga Italy 20 502 0.5× 394 0.6× 550 1.3× 312 0.9× 213 0.8× 60 1.3k
Artur Słupianek United States 23 1.2k 1.2× 986 1.6× 602 1.5× 649 1.8× 352 1.3× 48 2.2k
Francesco Paolo Tambaro United States 16 789 0.8× 294 0.5× 262 0.6× 309 0.8× 211 0.8× 40 1.3k
Véronique Mansat‐De Mas France 25 1.3k 1.3× 1.4k 2.3× 546 1.3× 428 1.2× 141 0.5× 57 2.5k
Hélène Lapillonne France 22 1.5k 1.4× 905 1.5× 495 1.2× 285 0.8× 145 0.6× 57 2.7k
Meaghan Wall Australia 23 983 1.0× 266 0.4× 276 0.7× 330 0.9× 232 0.9× 57 1.6k

Countries citing papers authored by Simone Boehrer

Since Specialization
Citations

This map shows the geographic impact of Simone Boehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Boehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Boehrer more than expected).

Fields of papers citing papers by Simone Boehrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Boehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Boehrer. The network helps show where Simone Boehrer may publish in the future.

Co-authorship network of co-authors of Simone Boehrer

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Boehrer. A scholar is included among the top collaborators of Simone Boehrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Boehrer. Simone Boehrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thépot, Sylvain, Simone Boehrer, Thomas Prébet, et al.. (2014). A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure. Leukemia Research. 38(12). 1430–1434. 13 indexed citations
2.
Tailler, Maximilien, Laura Senovilla, Élodie Lainey, et al.. (2011). Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene. 31(30). 3536–3546. 49 indexed citations
3.
Boehrer, Simone, Lionel Adès, Nicolas Tajeddine, et al.. (2009). Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene. 28(22). 2205–2218. 43 indexed citations
4.
Adès, Lionel, Simone Boehrer, Thomas Prébet, et al.. (2008). Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study. Blood. 113(17). 3947–3952. 107 indexed citations
5.
Boehrer, Simone, Lionel Adès, Lorenzo Galluzzi, et al.. (2008). Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A preclinical comparison. Biochemical Pharmacology. 76(11). 1417–1425. 26 indexed citations
6.
Fabre, Claire, J. Grosjean, Maximilien Tailler, et al.. (2008). A novel effect of DNA methyltransferase and histone deacetylase inhibitors : NFκB inhibition in malignant myeloblasts. Cell Cycle. 7(14). 2139–2145. 41 indexed citations
7.
Göttig, Stephan, et al.. (2007). Inhibition of Osteosarcoma Cell Proliferation by the Hedgehog-Inhibitor Cyclopamine. Journal of Chemotherapy. 19(5). 554–561. 23 indexed citations
8.
Nowak, Daniel, Simone Boehrer, Dieter Hoelzer, et al.. (2007). Src kinase inhibitors induce apoptosis and mediate cell cycle arrest in lymphoma cells. Anti-Cancer Drugs. 18(9). 981–995. 10 indexed citations
9.
Boehrer, Simone, Daniel Nowak, Elena Puccetti, et al.. (2006). Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis. Leukemia Research. 30(5). 597–605. 21 indexed citations
10.
Fabre, Claire, Thomas Braun, J. Grosjean, et al.. (2006). Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene. 26(16). 2299–2307. 40 indexed citations
11.
Chow, Kai Uwe, Paris S. Mitrou, Simone Boehrer, Daniel Nowak, & Dieter Hoelzer. (2006). The Molecular Biology of TRAIL-Mediated Signaling and its PotentialTherapeutic Exploitation in Hematopoietic Malignancies. Current Medicinal Chemistry. 13(18). 2091–2100. 11 indexed citations
12.
Boehrer, Simone, Daniel Nowak, Seung Wook Kim, et al.. (2005). Expression of Daxx sensitizes Jurkat T-cells to the apoptosis-inducing effect of chemotherapeutic agents. Pharmacological Research. 51(4). 367–374. 4 indexed citations
13.
Bug, Gesine, Stefan Klein, Bernd Hertenstein, et al.. (2005). High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation. Annals of Hematology. 84(11). 748–754. 11 indexed citations
14.
Puccetti, Elena, Kai Uwe Chow, Marion Bergmann, et al.. (2004). Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185BCR-ABL in hematopoietic cells. Experimental Hematology. 32(7). 649–656. 7 indexed citations
15.
Boehrer, Simone, Daniel Nowak, Dieter Hoelzer, et al.. (2004). Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways. Cellular Signalling. 17(5). 581–595. 16 indexed citations
16.
Boehrer, Simone, Daniel Nowak, Marion Bergmann, et al.. (2004). In malignant myeloid cells expression of Daxx downregulates expression of p53 and of the inhibitors of apoptosis proteins. The Hematology Journal. 5(6). 513–518. 1 indexed citations
17.
Bergmann, Marion, et al.. (2004). Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis. Annals of Hematology. 83(10). 646–53. 12 indexed citations
18.
19.
Boehrer, Simone, et al.. (2002). Cytotoxic Activity of T- and NK-cell Lymphoma Cells is not Dependent on a Mature Cytotoxic Phenotype. Leukemia & lymphoma. 43(12). 2363–2368. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmela Gurrieri Breakdown of academic impact, for papers by Yosuke Minami Breakdown of academic impact, for papers by Seong Lin Khaw Breakdown of academic impact, for papers by Keita Kirito Breakdown of academic impact, for papers by Francesca Arruga Breakdown of academic impact, for papers by Artur Słupianek Breakdown of academic impact, for papers by Francesco Paolo Tambaro Breakdown of academic impact, for papers by Véronique Mansat‐De Mas Breakdown of academic impact, for papers by Hélène Lapillonne Breakdown of academic impact, for papers by Meaghan Wall
Rankless by CCL
2026